Search

for
Search:

Glossary

Similar Terms

Erythropoietin

Learn

0 / 0 results

— no results

Research

5 / 85 results

Skin Regeneration with Conical and Hair Follicle Structure of Deep Second-Degree Scalding Injuries via Combined Expression of the EPO Receptor and Beta Common Receptor by Local Subcutaneous Injection of Nanosized rhEPO

research Skin Regeneration with Conical and Hair Follicle Structure of Deep Second-Degree Scalding Injuries via Combined Expression of the EPO Receptor and Beta Common Receptor by Local Subcutaneous Injection of Nanosized rhEPO

15 citations, March 2012 in “International journal of nanomedicine”

Local injections of nanosized rhEPO can speed up skin healing and improve quality after deep second-degree burns.

research Human Hair Follicles Are an Extrarenal Source and a Nonhematopoietic Target of Erythropoietin

71 citations, May 2007 in “The FASEB journal”

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

research Erythropoietin Promotes Hair Shaft Growth in Cultured Human Hair Follicles and Modulates Hair Growth in Mice

17 citations, May 2010 in “Journal of Dermatological Science”

Erythropoietin helps hair grow and could be a potential treatment for hair loss.

Transgenic Erythropoietin Overexpression Inhibits Dermal Fat Formation and HIF1a in the Skin and Causes Telogen Effluvium in Mouse Pups During the First Hair Cycle

research Transgenic Erythropoietin Overexpression Inhibits Dermal Fat Formation and HIF1a in the Skin and Causes Telogen Effluvium in Mouse Pups During the First Hair Cycle

June 2024 in “Diabetes”

Erythropoietin overexpression disrupts hair growth and fat formation in mice.

research The JAK/STAT Signaling Pathway: From Bench to Clinic

489 citations, November 2021 in “Signal Transduction and Targeted Therapy”

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

View more "epo receptor" in research →

Community Join

1 / 1 results

community HLT Megathread on HMI-115 (key takeaways in comments)

in Research/Science 39 upvotes 1 year ago

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.